Back to Danaher

Danaher News

DHR

Danaher Board Expands to 13 Members

Danaher (DHR) adds two directors, expanding its board to 13; director Spoon to retire in 2027. Governance implications amid recent acquisitions and leadership changes.

DHR

DHR: Founders Waive August 2026 RSUs

Danaher (DHR) founders Steven and Mitchell Rales waive rights to August 2026 RSUs. Key implications for investors on 2026-10-13.

DHR

Danaher CEO Transition: Julie Montgomery Named

Danaher (DHR) names Julie Montgomery CEO and grants executive equity awards. Key financials, segment mix, and investor implications on 2026-08-03.

DHR

Danaher Issues CHF 2.8B Senior Notes

Danaher (DHR) raises CHF 2.8B via seven-series senior notes on 2026-06-03. Key implications for debt profile, capital strategy and investor considerations.

DHR

Danaher to Acquire Masimo for $9.9B

Danaher (DHR) agrees to buy Masimo in a $9.9B cash deal, expanding its diagnostics business; strategic context, financials, and risks for investors.

DHR

Danaher CEO John Schwieters to Step Down

Danaher (DHR) says CEO John T. Schwieters will leave the company's board at the 2026 AGM, reducing board size. Key investor implications and context.

DHR

Danaher (DHR) Approves 35M Share Buyback

Danaher (DHR) board authorizes 35 million-share repurchase (≈4.9% of outstanding). Read financial context, balance sheet and shareholder-return analysis.

DHR

Danaher Revises Shareholder Rights Rules (DHR)

Danaher (DHR) updates procedures for shareholder proposals and nominations, altering submission and nomination processes per company disclosure.